Clinical Trial Update: Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation [NA]

View source ↗

Summary

A clinical trial evaluating posterior wall substrate modification using irreversible electroporation for paroxysmal atrial fibrillation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Paroxysmal Atrial Fibrillation

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Atrial Fibrillation Paroxysmal | NA | Status: TERMINATED